ArticleAmerican journal of respiratory and critical care medicine2021

Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.

Roham T Zamanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.